Lumakras Plus Vectibix improves PFS in colorectal cancer
Patients with colorectal cancer had improved progression-free survival with the combination of Lumaclas and Vectibix. Treatment with Lumaclas (sotorasib) in combination with Vectibix (panitumumab) at multiple dose levels significantly increases patient progression-free survival (PFS) and disease progression from random assignment in clinical trials compared to standard of care (SOC). (time to progression or death).Have chemotherapy-resistant […]